| systematic review | Q1504425 |
| scholarly article | Q13442814 |
| P50 | author | Sonya J Snedecor | Q118489410 |
| Lavanya Sudharshan | Q118489423 | ||
| P2093 | author name string | Michael S Keith | |
| Jimmy D Bartlett | |||
| P2860 | cites work | Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye | Q24794134 |
| Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study | Q28246849 | ||
| The corneal pain system. Part I: the missing piece of the dry eye puzzle | Q33353030 | ||
| New testing options for diagnosing and grading dry eye disease | Q33774520 | ||
| Development of the 25-item National Eye Institute Visual Function Questionnaire | Q34083677 | ||
| Diagnosing the severity of dry eye: a clear and practical algorithm | Q34092386 | ||
| The economic burden of dry eye disease in the United States: a decision tree analysis | Q34147677 | ||
| The epidemiology of dry eye in Melbourne, Australia | Q34471837 | ||
| The relationship between clinical signs and dry eye symptoms. | Q35208749 | ||
| Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study | Q35547511 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease | Q35957497 | ||
| Statistics corner: A guide to appropriate use of correlation coefficient in medical research | Q36622758 | ||
| Tear cytokine profiles in dysfunctional tear syndrome. | Q36637791 | ||
| Tear osmolarity in Sjögren syndrome | Q36859607 | ||
| Advances in understanding and managing dry eye disease | Q37206550 | ||
| The challenge of dry eye diagnosis | Q37233339 | ||
| What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? | Q37397203 | ||
| Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome | Q37457256 | ||
| The association between symptoms of discomfort and signs in dry eye. | Q37641435 | ||
| Minimal clinically important difference for the ocular surface disease index | Q37672025 | ||
| The cellular mechanisms of dry eye: from pathogenesis to treatment. | Q38108573 | ||
| Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca | Q38176265 | ||
| Dry eye symptoms and signs in long-term contact lens wearers | Q39388364 | ||
| Prevalence of dry eye among the elderly | Q39457390 | ||
| Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome | Q39988625 | ||
| Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. | Q42684410 | ||
| Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome | Q42940964 | ||
| Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study | Q42966054 | ||
| Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study | Q43448087 | ||
| Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications | Q43482891 | ||
| Association of dry eye signs and symptoms with tear lactoferrin concentration | Q43519461 | ||
| Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China | Q44516287 | ||
| The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
| Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. | Q44757521 | ||
| The lack of association between signs and symptoms in patients with dry eye disease | Q45122466 | ||
| Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren's syndrome. | Q45254744 | ||
| Reflex epiphora in patients with dry eye symptoms: role of variable time Schirmer-1 test | Q46587363 | ||
| Analysis of the correlations of mucins, inflammatory markers, and clinical tests in dry eye. | Q46716997 | ||
| Evaluation of dry eye signs and symptoms in patients with systemic sclerosis | Q48007930 | ||
| An objective approach to dry eye disease severity | Q48343172 | ||
| Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. | Q50548182 | ||
| Staining patterns in dry eye syndrome: rose bengal versus lissamine green. | Q50589280 | ||
| Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. | Q50933029 | ||
| Temporal stability in the perception of dry eye ocular discomfort symptoms. | Q51030563 | ||
| Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. | Q51370917 | ||
| A standardized visual scale for evaluation of tear fluorescein clearance. | Q51392414 | ||
| Impression cytology with scanning electron microscopy: a new method in the study of conjunctival microvilli. | Q51911432 | ||
| Understanding correlation coefficients and regression. | Q52650359 | ||
| Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. | Q54301170 | ||
| Analysis of inflammatory cytokines in the tears of dry eye patients. | Q54467014 | ||
| Alterations of Tear Neuromediators in Dry Eye Disease | Q61196350 | ||
| Association of clinical diagnostic tests and dry eye surveys: the NEI-VFQ-25 and the OSDI | Q73072059 | ||
| Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
| Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms | Q77319402 | ||
| Validation and repeatability of a short questionnaire for dry eye syndrome | Q79826261 | ||
| The reliability and validity of McMonnies Dry Eye Index | Q79960357 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| Age-related modifications of corneal sensitivity | Q80501522 | ||
| Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome | Q81151525 | ||
| Ocular surface disease index for the diagnosis of dry eye syndrome | Q81525535 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 1719-30 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Associations between signs and symptoms of dry eye disease: a systematic review | |
| P478 | volume | 9 |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q36335761 | Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease |
| Q90574523 | Association between dry eye symptoms and signs |
| Q50201362 | Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. |
| Q50086774 | Blink: Characteristics, Controls, and Relation to Dry Eyes. |
| Q91947400 | Clinical utility of SPECT/CT and CT-dacryocystography-enhanced dacryoscintigraphy in the imaging of lacrimal drainage system obstruction |
| Q95729513 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study |
| Q58122088 | Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1 |
| Q48236970 | Controlled Adverse Environment Chambers in Dry Eye Research. |
| Q37683370 | Correlation Analysis of Ocular Symptoms and Signs in Patients with Dry Eye. |
| Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
| Q53122748 | Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye? |
| Q36009304 | Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility. |
| Q90079719 | Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy |
| Q90319698 | Dry Eye Indexes Estimated by Keratograph 5M of Systemic Lupus Erythematosus Patients without Secondary Sjögren's Syndrome Correlate with Lupus Activity |
| Q36707249 | Effects of Lutein on Hyperosmoticity-Induced Upregulation of IL-6 in Cultured Corneal Epithelial Cells and Its Relevant Signal Pathways. |
| Q90223560 | Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study |
| Q99551257 | In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay |
| Q39069560 | Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease |
| Q45037685 | Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials |
| Q38608475 | Lifitegrast for the treatment of dry eye disease in adults |
| Q64106425 | Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity |
| Q47590974 | Serum levels of vitamin A, visual function and ocular surface after bariatric surgery. |
| Q92372126 | Tear Metabolomics in Dry Eye Disease: A Review |
| Q33756582 | The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research |
| Q88362505 | The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population |
| Q41352146 | The role of lipids in corneal diseases and dystrophies: a systematic review |
| Q50110517 | Therapeutic inhibitors for the treatment of dry eye syndrome. |
| Q50025206 | Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program. |
| Q57479267 | Validation of an Objective Measure of Dry Eye Severity |
| Q58769015 | Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis |
| Q89717800 | [Differential diagnoses of dry eye syndrome and blepharitis] |
Search more.